hydrochlorothiazide and eudragit-e

hydrochlorothiazide has been researched along with eudragit-e in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goyanes, A; Martínez-Pacheco, R; Souto, C1
Abbadi, I; Alhnan, MA; Aziz, D; Isreb, A; Isreb, M; Sadia, M; Selo, A; Timmins, P1

Other Studies

2 other study(ies) available for hydrochlorothiazide and eudragit-e

ArticleYear
Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2011, Volume: 79, Issue:3

    Topics: Cellulose; Compressive Strength; Drug Compounding; Excipients; Hydrochlorothiazide; Methacrylates; Methylmethacrylates; Microscopy, Electron, Scanning; Particle Size; Powder Diffraction; Solubility; Spectrophotometry, Infrared; Surface Properties; X-Ray Diffraction

2011
From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Oct-15, Volume: 123

    Topics: Administration, Oral; Antihypertensive Agents; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Enalapril; Hydrochlorothiazide; Kinetics; Polymethacrylic Acids; Printing, Three-Dimensional; Solubility; Tablets; Technology, Pharmaceutical

2018